Universe · entity
SILVERARC CAPITAL MANAGEMENT, LLC
Institutional manager (13F) · CIK 1816307
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $827M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | KALVISTA PHARMACEUTICALS INC | $58M | 2,876,407 |
| 2 | DIANTHUS THERAPEUTICS INC | $55M | 654,746 |
| 3 | COGENT BIOSCIENCES INC | $51M | 1,314,189 |
| 4 | CELCUITY INC | $41M | 357,903 |
| 5 | IMMUNOME INC | $40M | 1,850,278 |
| 6 | KODIAK SCIENCES INC | $38M | 991,930 |
| 7 | NUVALENT INC | $36M | 354,914 |
| 8 | ABIVAX SA | $34M | 302,530 |
| 9 | MONTE ROSA THERAPEUTICS INC | $33M | 2,002,040 |
| 10 | ERASCA INC | $30M | 1,851,812 |
| 11 | ASCENDIS PHARMA A/S | $29M | 124,658 |
| 12 | UROGEN PHARMA LTD | $27M | 1,503,045 |
| 13 | RHYTHM PHARMACEUTICALS INC | $27M | 306,000 |
| 14 | PRAXIS PRECISION MEDICINES I | $23M | 71,552 |
| 15 | ZENAS BIOPHARMA INC | $22M | 1,135,935 |
| 16 | SYNDAX PHARMACEUTICALS INC | $21M | 888,987 |
| 17 | CENTESSA PHARMACEUTICALS PLC | $19M | 466,345 |
| 18 | SCHOLAR ROCK HLDG CORP | $17M | 339,613 |
| 19 | ALKERMES PLC | $16M | 460,314 |
| 20 | ORIC PHARMACEUTICALS INC | $14M | 1,100,010 |
| 21 | DISC MEDICINE INC | $13M | 196,028 |
| 22 | HELIX ACQUISITION CORP III | $12M | 1,208,986 |
| 23 | XENON PHARMACEUTICALS INC | $11M | 197,759 |
| 24 | CG ONCOLOGY INC | $11M | 166,349 |
| 25 | IMMUNOVANT INC | $10M | 414,236 |
| 26 | SPYRE THERAPEUTICS INC | $9M | 186,618 |
| 27 | BIOGEN INC | $9M | 50,967 |
| 28 | GUARDANT HEALTH INC | $9M | 98,514 |
| 29 | VAXCYTE INC | $8M | 144,981 |
| 30 | SAVARA INC | $8M | 1,430,982 |
| 31 | BENITEC BIOPHARMA INC | $8M | 717,725 |
| 32 | ORUKA THERAPEUTICS INC | $7M | 150,908 |
| 33 | COMPUGEN LTD | $7M | 3,315,845 |
| 34 | TREVI THERAPEUTICS INC | $6M | 511,127 |
| 35 | INSMED INC | $6M | 35,850 |
| 36 | VERACYTE INC | $6M | 179,700 |
| 37 | CERUS CORP | $6M | 3,176,547 |
| 38 | CELLDEX THERAPEUTICS INC NEW | $6M | 178,378 |
| 39 | C4 THERAPEUTICS INC | $5M | 1,911,785 |
| 40 | CYTOKINETICS INC | $5M | 71,203 |
| 41 | CLIMB BIO INC | $5M | 684,908 |
| 42 | COMPASS THERAPEUTICS INC | $5M | 859,049 |
| 43 | SURROZEN INC | $4M | 144,255 |
| 44 | CONTINEUM THERAPEUTICS INC | $4M | 301,729 |
| 45 | ZURA BIO LTD | $3M | 560,651 |
| 46 | FULCRUM THERAPEUTICS INC | $3M | 419,949 |
| 47 | ABEONA THERAPEUTICS INC | $3M | 648,942 |
| 48 | CAMP4 THERAPEUTICS CORP | $3M | 653,594 |
| 49 | ANNEXON INC | $3M | 496,461 |
| 50 | ELUTIA INC | $3M | 2,498,020 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.